Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 85151-85200 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05172258
Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck
PHASE2
Active, not recruiting
52 participants
Started: Jul 26, 2022 · Completed: Jun 30, 2027
15 conditions
1 sponsor
20 locations
NCT05377658
AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer
PHASE2
Recruiting
43 participants
Started: Jul 26, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT06083636
Improvement of Laboratory Diagnostics in Hypothyroid Patients Using Levothyroxine
N/A
Recruiting
500 participants
Started: Jul 26, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05476432
HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study
PHASE3
Recruiting
300 participants
Started: Jul 26, 2022 · Completed: Oct 1, 2026
1 condition
3 sponsors
3 locations
NCT04591002
Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)
PHASE2
Recruiting
43 participants
Started: Jul 26, 2022 · Completed: Oct 30, 2028
1 condition
1 sponsor
2 locations
NCT04671212
Discarded Bone Marrow for Hematology Research
N/A
Recruiting
50 participants
Started: Jul 26, 2022 · Completed: Jan 31, 2035
1 condition
1 sponsor
1 location
NCT05357144
AmbassADDOrs for Health Study
NA
Recruiting
140 participants
Started: Jul 26, 2022 · Completed: Dec 31, 2026
1 condition
5 sponsors
2 locations
NCT04078555
A Study to Evaluate ENERGI-F703 GEL in Venous Leg Ulcer
PHASE2
Recruiting
80 participants
Started: Jul 26, 2022 · Completed: Jun 15, 2025
1 condition
1 sponsor
1 location
NCT05417685
Digital Care Programs for Musculoskeletal Health
N/A
Enrolling by invitation
300,000 participants
Started: Jul 26, 2022 · Completed: Apr 1, 2032
1 condition
1 sponsor
1 location
NCT05586984
Transvaginal Sacrospinous Hysteropexy Versus Laparoscopic Uterine Lateral Suspension
N/A
Recruiting
90 participants
Started: Jul 26, 2022 · Completed: Dec 31, 2029
2 conditions
1 sponsor
1 location
NCT05013736
Baby Brain Recovery Study
N/A
Recruiting
65 participants
Started: Jul 26, 2022 · Completed: Sep 30, 2026
1 condition
2 sponsors
1 location
NCT05613569
A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study
N/A
Active, not recruiting
5 participants
Started: Jul 26, 2022 · Completed: Apr 30, 2027
1 condition
1 sponsor
1 location
NCT05320926
Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial
NA
Recruiting
3,744 participants
Started: Jul 26, 2022 · Completed: Jul 10, 2028
1 condition
1 sponsor
1 location
NCT05413239
Healthy And Positive Pathways for Young People With Type 1 Diabetes (HAPPY T1D)
NA
Active, not recruiting
191 participants
Started: Jul 26, 2022 · Completed: Nov 30, 2025
1 condition
3 sponsors
2 locations
NCT05421728
Effectiveness of Engaging in Advance Care Planning Talks (ENACT) Group Visits in Primary Care for Older Adults With and Without Alzheimer's Disease
NA
Active, not recruiting
516 participants
Started: Jul 26, 2022 · Completed: May 1, 2027
2 conditions
2 sponsors
8 locations
NCT05571384
High Intensity Body-weight Circuit Training Feasibility and Efficacy for in Middle Aged Persons With Type 2 Diabetes
NA
Recruiting
42 participants
Started: Jul 26, 2022 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT05657067
Effectiveness and Feasibility of Structured EFFT
NA
Recruiting
15 participants
Started: Jul 26, 2022 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT05528458
Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma
PHASE2
Recruiting
59 participants
Started: Jul 26, 2022 · Completed: Dec 1, 2029
1 condition
1 sponsor
1 location
NCT04906213
CardioRenal Effects of SGLT2 Inhibition in Kidney Transplant Recipients
PHASE2
Recruiting
72 participants
Started: Jul 25, 2022 · Completed: Aug 31, 2026
2 conditions
1 sponsor
1 location
NCT05265364
Acute Toxicity After Moderate Hypo-fractionated Intensity Modulated Radiotherapy IMRT or Prostate Cancer
N/A
Active, not recruiting
50 participants
Started: Jul 25, 2022 · Completed: Dec 12, 2024
1 condition
1 sponsor
1 location
NCT06085794
Standard PCNL Vs Endoscopic Combined Intrarenal Surgery (ECIRS) for Complex Nephrolithiasis in Obese Patients
NA
Recruiting
100 participants
Started: Jul 25, 2022 · Completed: Jan 31, 2024
1 condition
1 sponsor
1 location
NCT06549621
Cardiotoxicity of Carbon Monoxide in Patients Treated With Hyperbaric Oxygen Therapy
N/A
Recruiting
66 participants
Started: Jul 25, 2022 · Completed: Oct 25, 2024
1 condition
1 sponsor
1 location
NCT05366829
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
PHASE2
Recruiting
35 participants
Started: Jul 25, 2022 · Completed: Jun 1, 2027
2 conditions
3 sponsors
2 locations
NCT05186064
Glioblastoma Targeted Treatment Option Maximization by WGS
NA
Recruiting
160 participants
Started: Jul 25, 2022 · Completed: Jul 1, 2025
1 condition
12 sponsors
1 location
NCT05263180
A Study of EMB-09 in Participants With Advanced or Metastatic Solid Tumors.
PHASE1
Recruiting
30 participants
Started: Jul 25, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
4 locations
NCT05501262
Comparative Effectiveness of Cryoablation Versus Steroid and Lidocaine Alone for Treatment of Morton's Neuroma
NA
Recruiting
32 participants
Started: Jul 25, 2022 · Completed: Dec 31, 2027
1 condition
3 sponsors
1 location
NCT05315674
Markers of COPD Exacerbations
N/A
Recruiting
150 participants
Started: Jul 25, 2022 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT05627700
AVL200 IOL for Treatment of Cataract and Presbyopia
NA
Recruiting
60 participants
Started: Jul 25, 2022 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT05268120
MRSA Decolonization in Complicated Carriage
NA
Recruiting
211 participants
Started: Jul 25, 2022 · Completed: May 1, 2028
1 condition
1 sponsor
1 location
NCT05468151
Cold Acclimation As a Modulator of Brown Adipose Tissue Function in Adults with Obesity
NA
Active, not recruiting
45 participants
Started: Jul 25, 2022 · Completed: Jul 1, 2026
1 condition
4 sponsors
1 location
NCT05335993
A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.
PHASE2
Active, not recruiting
10 participants
Started: Jul 25, 2022 · Completed: Jul 30, 2025
7 conditions
2 sponsors
3 locations
NCT05100381
Effectiveness of Dry Needling in Patients With Chronic Nonspecific Low Back Pain
NA
Recruiting
40 participants
Started: Jul 25, 2022 · Completed: Dec 30, 2026
1 condition
1 sponsor
1 location
NCT05484635
Mesh Removal Versus No Mesh Removal for Chronic Groin Pain After Inguinal Hernia Repair
NA
Recruiting
70 participants
Started: Jul 25, 2022 · Completed: Jul 1, 2028
2 conditions
1 sponsor
1 location
NCT05468255
The Impact of Removal of Exercise on Glycemic Control and Vascular Health in Older Active Adults
NA
Recruiting
40 participants
Started: Jul 25, 2022 · Completed: Apr 1, 2025
3 conditions
1 sponsor
1 location
NCT05340348
Patientheque in Patients With a Psychosis .
NA
Recruiting
250 participants
Started: Jul 25, 2022 · Completed: Jul 25, 2032
3 conditions
1 sponsor
1 location
NCT05636384
SupporTive Care At Home Research for Patients With Advanced Cancer (STAHR-cancer)
NA
Recruiting
396 participants
Started: Jul 25, 2022 · Completed: Dec 31, 2026
4 conditions
6 sponsors
6 locations
NCT05382286
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
PHASE3
Active, not recruiting
443 participants
Started: Jul 25, 2022 · Completed: Feb 28, 2027
2 conditions
2 sponsors
504 locations
NCT05352828
Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy
PHASE1
Active, not recruiting
15 participants
Started: Jul 25, 2022 · Completed: Dec 15, 2037
3 conditions
2 sponsors
5 locations
NCT05389904
Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides Difficile
NA
Recruiting
300 participants
Started: Jul 25, 2022 · Completed: Aug 31, 2026
1 condition
5 sponsors
1 location
NCT05442632
Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before Hepatectomy
PHASE2
Recruiting
96 participants
Started: Jul 25, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05472987
Robotic Versus Open Ventral Hernia Repair
NA
Recruiting
200 participants
Started: Jul 25, 2022 · Completed: Aug 1, 2027
1 condition
1 sponsor
4 locations
NCT05422027
Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma
PHASE1/PHASE2
Recruiting
42 participants
Started: Jul 25, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
4 locations
NCT04567511
Hemlibra in Mild Hemophilia A
PHASE4
Recruiting
20 participants
Started: Jul 25, 2022 · Completed: Jul 31, 2027
1 condition
2 sponsors
1 location
NCT05407519
A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection
PHASE2
Recruiting
40 participants
Started: Jul 25, 2022 · Completed: Jun 30, 2026
1 condition
4 sponsors
1 location
NCT05515042
Phase 2a Trial to Evaluate Safety and Immunogenicity of COVID-19 Vaccine Strategies in HIV-infected/Uninfected Adults.
PHASE2
Active, not recruiting
694 participants
Started: Jul 25, 2022 · Completed: Dec 31, 2024
1 condition
2 sponsors
5 locations
NCT05700006
Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging
N/A
Active, not recruiting
100 participants
Started: Jul 25, 2022 · Completed: Jul 31, 2026
3 conditions
1 sponsor
1 location
NCT05315258
Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma
PHASE2
Active, not recruiting
850 participants
Started: Jul 25, 2022 · Completed: Jun 30, 2027
2 conditions
2 sponsors
10 locations
NCT05436756
Chronic Post-leptospirosis Manifestations in Reunion
NA
Recruiting
198 participants
Started: Jul 25, 2022 · Completed: Jul 24, 2026
1 condition
1 sponsor
4 locations
NCT05425147
Correlation Between Perioperative Autonomic Function and Post-induction Hypotension in Elderly Patients
N/A
Recruiting
180 participants
Started: Jul 25, 2022 · Completed: Mar 1, 2025
1 condition
1 sponsor
1 location
NCT05331664
Dropless Pars Plana Vitrectomy Study
PHASE4
Recruiting
168 participants
Started: Jul 25, 2022 · Completed: Jan 30, 2027
1 condition
1 sponsor
1 location
Previous
1
More pages
1701
1702
1703
1704
1705
1706
1707
More pages
2369
Next